About Rishi Reddy
Rishi Reddy is managing director and head of venture and growth equity at Tarsadia Investments. Tarsadia led the growth equity round that ClinTrial Research announced on December 17, 2025. ClinTrial Research is a clinical research organization in North Carolina, and Reddy is a director of the company.
In the announcement, Reddy said Tarsadia had studied site networks for more than two years before choosing ClinTrial Research. He said Tarsadia and ClinTrial Research share a focus on AI-enabled technology platforms.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Rishi Reddy in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rishi Reddy works with at each company, as listed on that company's latest Form D.
Sources
- SECChronicle Bio, Inc. Form D/A, filed Nov 12, 2026
- SECClinTrial Research, Inc. Form D, filed Oct 28, 2026
- SECAvantstay, Inc. Form D, filed Jul 13, 2026
- SECFathom, Inc. Form D, filed Jan 18, 2023
- P3ClinTrial Research and Tarsadia Investments Partner to Build Next Generation Site Network (PR Newswire, December 17, 2025)
- P1ClinTrial Research website